Beck Bode LLC Cuts Stock Position in HealthEquity, Inc. $HQY

Key Points

• Beck Bode LLC reduced its position in HealthEquity, Inc. (HQY) by 39.3% in Q1, holding $475,000 worth of the stock after selling 3,473 shares.
• Several institutional investors increased their stakes in HealthEquity during the same period, with notable increases including a 53.0% rise by B. Metzler seel. Sohn & Co. AG.
• HealthEquity received multiple analysts' upgrades, with the average price target now set at $118.55, reflecting a consensus "Buy" rating across most evaluations.

Beck Bode LLC decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 39.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,375 shares of the company's stock after selling 3,473 shares during the period. Beck Bode LLC's holdings in HealthEquity were worth $475,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in HQY. Ieq Capital LLC increased its holdings in shares of HealthEquity by 4.4% in the first quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock worth $260,000 after buying an additional 123 shares during the period. Xponance Inc. increased its holdings in shares of HealthEquity by 1.1% in the first quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after buying an additional 136 shares during the period. Fifth Third Bancorp increased its holdings in shares of HealthEquity by 17.5% in the first quarter. Fifth Third Bancorp now owns 955 shares of the company's stock worth $84,000 after buying an additional 142 shares during the period. Greenleaf Trust increased its holdings in shares of HealthEquity by 7.8% in the first quarter. Greenleaf Trust now owns 2,407 shares of the company's stock worth $213,000 after buying an additional 175 shares during the period. Finally, State of Alaska Department of Revenue increased its holdings in shares of HealthEquity by 1.8% in the first quarter. State of Alaska Department of Revenue now owns 10,136 shares of the company's stock worth $895,000 after buying an additional 180 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Up 1.2%

Shares of HQY traded up $1.04 during mid-day trading on Monday, reaching $89.33. The company had a trading volume of 1,519,644 shares, compared to its average volume of 946,119. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The firm has a 50-day moving average price of $95.50 and a 200 day moving average price of $95.57. HealthEquity, Inc. has a 52 week low of $73.84 and a 52 week high of $116.65. The company has a market capitalization of $7.72 billion, a price-to-earnings ratio of 65.20, a price-to-earnings-growth ratio of 1.38 and a beta of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.The firm had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. During the same period in the previous year, the firm posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Analyst Upgrades and Downgrades

HQY has been the topic of several analyst reports. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. The Goldman Sachs Group raised their target price on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. JMP Securities raised their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, June 5th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, HealthEquity has an average rating of "Buy" and a consensus target price of $117.82.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president directly owned 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the sale, the director owned 75,000 shares of the company's stock, valued at approximately $8,403,750. This represents a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 291,744 shares of company stock worth $32,705,007. Insiders own 1.50% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.